STOCK TITAN

MultiPlan Corporation Announces Annual Meeting Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

MultiPlan Corporation (NYSE: MPLN) held its Annual Meeting on May 27, 2021, where key corporate decisions were made. The Company's stockholders elected Paul D. Emery, C. Martin Harris, Mark H. Tabak, and William L. Veghte as Class I directors. Additionally, stockholders approved the compensation of named executive officers on an advisory basis and expressed a preference for annual advisory votes on executive compensation. The selection of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm was also ratified.

Positive
  • Election of experienced Class I directors, enhancing board expertise.
  • Approval of executive compensation suggests alignment with shareholder interests.
  • Ratification of independent auditing firm may bolster investor confidence.
Negative
  • None.

MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, announced the results from its May 27, 2021 Annual Meeting. The Company filed a Current Report on Form 8-K with the Securities and Exchange Commission on June 1, 2021 with the final vote counts from last week’s meeting.

At the meeting, Paul D. Emery, C. Martin Harris, Mark H. Tabak, and William L. Veghte were elected to serve as Class I directors on the Board of Directors.

In addition, stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, indicated their preference for an annual advisory vote to approve the compensation of our named executive officers and ratified the selection of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm.

About MultiPlan

MultiPlan is committed to helping healthcare payors manage the cost of care, improve their competitiveness and inspire positive change. Leveraging sophisticated technology, data analytics and a team rich with industry experience, MultiPlan interprets clients’ needs and customizes innovative solutions that combine its payment integrity, network-based and analytics-based services. MultiPlan is a trusted partner to over 700 healthcare payors in the commercial health, government, property and casualty and markets. For more information, visit multiplan.com.

FAQ

What were the results of MultiPlan's Annual Meeting on May 27, 2021?

At the Annual Meeting, MultiPlan's stockholders elected four directors and approved executive compensation on an advisory basis.

Who were elected to the Board of Directors of MultiPlan?

Paul D. Emery, C. Martin Harris, Mark H. Tabak, and William L. Veghte were elected as Class I directors.

What advisory vote did MultiPlan stockholders prefer?

Stockholders indicated a preference for annual advisory votes on the compensation of named executive officers.

Which accounting firm was ratified by MultiPlan's stockholders?

PricewaterhouseCoopers LLP was ratified as the Company's Independent Registered Public Accounting Firm.

MultiPlan Corporation

NYSE:MPLN

MPLN Rankings

MPLN Latest News

MPLN Stock Data

103.01M
8.33M
7.95%
81.52%
1.64%
Health Information Services
Services-business Services, Nec
Link
United States of America
NEW YORK